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 Behcet's disease is an autoimmune, rare, and 
severe chronic multisystemic inflammatory disease and 
characterized by recurrent oral aphthous ulcers, genital 
ulcers, skin lesions, and both anterior and posterior 
uveitis1. It is observed commonly among population in 
Mediterrania, Middle East and East Asia. The pathogenesis 
of Behcet’s disease is still unknown. Infection, HLA-B51 
and environmental factor are some hypothesis that 
suspected to be the cause of Behcet’s disease2.  
 Ocular manifestation of Behcet’s disease can be 
sight threatening because of  relapsing uveitis that may 
involve anterior segment, posterior segment, or both and 
may have several complication including optic atrophy, 
retinal detachment, and secondary glaucoma. Which can 
all lead to blindness if treatment is delayed2. The goal 
treatment of Behcet’s disease are to control chronic 
inflammation and decrease the number of relapse with 
corticosteroid and immunosuppressive theraphy3. 
Azathioprine and corticosteroid are recommended as initial 
therapy for patient with ocular manifestation of Behcet’s 
Disease4. 
 Cataract is the most frequent complication in 
anterior segment in patient with Behcet’s disease because 
of recurrent attack of uveitis and corticosteroid use to 
control the disease. Like the other complicated cataract 
cause by uveitis, the surgical decision is based on etiology, 
duration and inflammation activity of the disease4. Surgical 
removal in such cataract requires different approach in pre 
and post-operative period to prevent the risk of immediate 
severe inflammation after surgery. The surgery also 
requires additional manipulation such as dissection of 
synechias and iris retractors. The implantation of 




 A of 35 years old man complained progressive 
visual loss since 6 months before admission on both eyes 
with VA 1 meter finger counting and NLP.  There was 
history of recurrent redness on both eyes accompanied by 
blurred vision and pain, oral aphtosis, and genital aphtosis 
since three years before admission but didn’t seek help 
because of low access to healthcare in his previous home. 
From anterior segment examination there was posterior 
synechia, cloudy lens, flare and cell on the right eye and 
pupil seclusion, rubeosis iridis and elevated IOP of 43.4 
mmHg on left eye suggesting chronic uveitis (fig.1).  
 
Figure 1. Slit lamp photograph of initial examination. Right eye with posterior synechia and cloudy lens and left 
eye with pupil seclusion and rubeosis iridis 
 Retinal vasculitis was found on posterior segment 
examination on right eye and there was echogenic lesion 
particle shaped with 20% echospike of RCS complex 
suggesting posterior uveitis found on USG on left eye.  
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Figure 2. Fundal photography of right eye showing retinal vasculitis (right) and  Ultrasonography of the left eye 
showing posterior uvetis (left). 
 The patient was diagnosed with Behcet’s disease 
and was given the combination of corticosteroid and 
immunosuppressive of methylprednisolone 16 mg three 
times a day and azathioprine 50 mg three times a day.  The 
patient also given topical corticosteroid, topical midryating 
and cyclopegic agent to prevent further synechia. 
Glaucoma medication was also given to control increased 
IOP. Despite all the medication, Behcet’s disease in this 
patient is hard to control because of the nature of recurrent 
uveitis in this disease. The patient also report side effect of 
prolonged corticosteroid use like weight gain and moon-
face. And there was also side effect of leukopenia and 
increased liver function that causing halt of the 
azathioprine use by several weeks.  
 After one year of medication, the combination on 
immunosuppressive and corticosteroid are able to control 
the disease. There were improvement of quieter condition 
on both eyes and decreased left eye IOP of 37.2 mmHg. 
But there are worsening of cataract condition of right eye 
(fig.3) causing decrease visual acuity to become LP (+). 
Cataract condition are making the evaluation of posterior 
segment difficult to be done but the ultrasonography shows 
that there are no posterior uveitis. Lens extraction with iris 
retractor was discussed as an attempt to improve the visual 
acuity and evaluate the condition of posterior segment.  
  
Figure 3. Slit lamp photograph and ultrasonography of right eye  after one year of medication 
The surgery was being done after inflammation 
were controlled and the anterior chamber is free from cells 
for at least three months. The patient was given his usual 
regimen of immunosuppressive  with additional IV methyl 
prednisolone 250 mg 4 times a day for 3 days before and 
after operation. The operation was done with 
phacoemulsification technique with synechia dissection 
and iris retractors. The surgery went uneventful and there 
was no complication during surgery. One day after the 
operation, there was no flare and cell in sight and there was 
improvement of visual acuity of hand movement.  
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Figure 4. Slit lamp examination one day post-op  
 Patient then discharged after three days 
observation and inflammation control with no recurrence 
of uveitis during the admission in hospital. Two weeks 
after the operation, there was membrane formation in the 
IOL and cells in anterior chamber (fig.5) despite the 
immunosuppressive and corticosteroid therapy. Visual 
acuity is still at hand movement and upon examination 
there was optic atrophy that causing decreased vision.  
 
Figure 5. Membrane formation after two weeks post op 
 
Discussion  
Behcet’s disease (BD) is a chronic, relapsing, 
inflammatory vascular disease known to affect adult male 
younger than 40 years old3. The etiology of Behçet’s 
disease is unknown, genetic and environmental factors are 
thought to be associated with the development and 
progression of the disease. Infectious agents, such as 
Herpes simplex virus, hepatitis viruses, Parvovirus, 
and Streptococcus sanguis have been predicted as causes 
of Behçet’s disease6.  
Clinical features of Behcet’s disease include oral 
and genital ulcers, ocular inflammation, skin lesions, and 
more rare condition such as articular, vascular, 
neurological, pulmonary, gastrointestinal, renal, vascular 
and genitourinary manifestations. The disease may start 
with one or more of the above symptoms but other 
symptoms may gradually appear over the years4.  
The ophthalmic manifestation of Behcet’s disease 
is seldom the initial manifestation and can occurs years 
after the first oral ulcers.  Uveitis is the most common 
symptom and occurs in approximately two-thirds of 
patients with Behcet’s Disease. The uveitis have feature of 
relapsing and can affect bilateral anterior and posterior 
segment of the eye.  and can be vision threatening if 
treatment is delayed3. A single attack will usually heal 
spontaneously without producing any sequelae. However  
because of the relapsing nature of it, it can lead to blindness 
if treatment is delayed. Most vision-threatening conditions 
were of posterior segment origin and were largely inversely 
correlated with the presence of genital ulcers and systemic 
vasculitis2,3. 
There are no gold standard criteria for the 
diagnosis of Behcet’s disease because there are no specific 
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laboratory tests or pathognomonic findings. Two of the 
most commonly used classification criteria are the ICBD 
(International Criteria for Behcet’s Disease) and the ISG 
(International Study Group) criteria. The ISG criteria states 
that recurrent oral ulcer that occurs at least three times a 
year, is mandatory for the diagnosis. In addition, two of the 
four major symptoms, including eye lesion, recurrent 
genital ulcers, skin lesions, and a positive pathergy test, are 
sufficient for the diagnosis of Behcet’s disease. Whereas 
ICBD states that there are four major and five minor 
criteria. The major criteria include recurrent aphthous 
ulcers, skin findings (similar of those erythema nodosum 
or acne and a pathergy test), genital ulcers, and ocular 
involvement. The minor criteria include arthritis, intestinal 
ulcers, epididymitis, vascular disease, and 
neuropsychiatric involvement. This diagnostic system 
requires only one major symptom in addition to typical 
ocular symptoms for the diagnosis of ocular Behcet’s 
Disease3,7. 
In this case the patient present with recurrent 
genital and oral ulcer for over three years prior to 
admission and patient also have recurrent red eye that have 
mild pain for the course of three years. Suggesting that 
Behcet’s disease of this patient had happen long before 
patient seek help to hospital. In the initial examination, 
there are the signs of active uveitis of flare and cells in 
anterior chamber, posterior uveitis and vasculitis. There 
were also signs of chronic uveitis in forms of posterior 
synechia, cloudy lens, and pupil seclusion. There was also 
elevated IOP on left eye with presence of rubeosis iridis, 
suggesting that the glaucoma of the left eye is caused by 
neovascular or uveitic glaucoma from the complication of 
chronic relapsing uveitis. Because of recurrent aphthous 
ulcers, skin findings, genital ulcers, and ocular 
involvement, this patient meet the classification criteria of 
Behcet’s Disease in both ICBD and ISG.  
The goal treatment of Behcet’s disease are to 
control chronic inflammation, reduce the frequency and 
severity of recurrences, and decrease the number of relapse 
to minimize the involvement of posterior segment. To be 
effective, treatment must be started early. Corticosteroids 
is the most useful agent in the treatment of explosive 
inflammation of the anterior and posterior segments, 
Prednisone doses of 1.5mg/kg/day (with taper) are most 
beneficial for controlling acute inflammation as well as 
pulse dose steroids (1 g intravenous methylprednisolone 
infusions daily) are often used for 3 days if  there are severe 
manifestation4. topically applied corticosteroid eye drops 
together with mydriatics or cycloplegic agents can often 
control the disease especially in mild anterior 
uveitis8.  Immunosuppressives can also be combined in 
those patients whose eye disease is refractory to treatment. 
Azathioprine and corticosteroid are recommended as the 
initial therapy for all patients with BD with inflammation 
of the posterior segment of the eye . a retrospective analysis 
of 157 consecutive patients with severe uveitis (active 
posterior uveitis or panuveitis) treated with corticosteroids 
(0.5–1 mg/kg/day) and azathioprine (2.5 mg/kg/day) 
revealed that posterior uveitis was controlled in 92.9% of 
patients, of whom 51.6% were complete responders and 
41.4% were partial responders9. In this case patient already 
got the combination of azathioprine 50 mg three times a 
day and methyl prednisolone 16 mg three times a day. 
Patient also got midryatic and cyclopegic drops for 
preventing further synechia and anti glaucoma medication 
for decreasing the IOP. Quiet condition of the eye and 
uveitic episode are controlled after one year of therapy, but 
visual acuity are decreased to light perception due to 
cataract. The posterior segment is difficult to evaluate but 
ultrasonography shows no posterior uveitis. 
Cataract in uveitis may develop as a result of the 
intraocular inflammation and chronic corticosteroid usage 
or both. Surgery is indicated whenever visual improvement 
can be expected and the eye has been free of inflammation 
for a minimum of 3 months. For successful surgery, the 
surgeon must ensure that uveitis should be inactive for at 
least 3 months preoperatively, systemic and topical 
steroids should be used prophylactically for 1 week 
preoperatively and continued postoperatively, 
immunosuppressive drugs should be continued. Additional 
step like synechiolysis, remove pupillary membranes, 
perform pupillary relaxing incisions or sphyncterotomies, 
or using iris retractor hooks are sometimes needed to 
maintain adequate pupil size during surgery. The surgeon 
must ensure complete removal of cortical material should 
take place, and one-piece PMMA posterior chamber 
intraocular lens should be used. The  surgeon and patient 
must understand the special nature of this surgery, its risks, 
and the prognosis for success 5,10. The cataract surgery in 
this patient are done with combination of corticosteroid and 
immunosuppressive agent as well as IV corticosteroid 
three days before and after operation. The surgery went 
uneventfull with phacoemulsification technique and IOL 
implantation with additional synechiolysis and iris 
retractors to maintain adequate pupil size.  
The outcomes of visual acuity after cataract 
extraction are guarded in patient with Behcet’s disease. 
Patients with Behçet's disease related to intraocular 
inflammation appeared to have a higher risk for 
complications and therefore worse outcomes than patients 
with other clinical etiologies of uveitis. Berker et al., 
reported results of 72.5% improvement in vision after 
surgery of phacoemulsification and intraocular lens 
implantation in patients with Behcet’s disease However, 
the vision got worse in 17.5% of the eyes. Most frequent 
complication reported by them was posterior capsular 
opacification in 37.5% of eyes. Other complications were 
posterior synchiae and severe inflammation. Posterior 
segment complications such as epiretinal membrane 
formation, cystoid macular edema, and optic atrophy11. In 
this patient despite the surgery being uneventful and 
intense medication support of immunosuppressive and 
corticosteroid agent, the visual outcomes after surgery did 
not improved much from light perception to hand 
movement. There was membrane formation behind the 
intraocular lens as fast as two weeks after surgery 
suggesting the formation of posterior capsular opacity 
which is one of the postoperative complications after 
cataract surgery in eyes with uveitis. Upon examination of 
posterior segment there was also optic atrophy wich is one 
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of chronic manifestation of Behcet’s disease that causing 
irreversible visual loss. 
 
Conclusion 
 In patient with chronic Behcet’s disease, ocular 
involvement can affect both anterior and posterior 
segments with poor visual outcome regarding its 
complication. Complications like retinal detachment, 
secondary glaucoma, and optic atrophy often cause 
irreversible visual loss. It is thus very important for an 
ophthalmologist to be able to predict which case of 
Behcet’s disease will pursue a vision-threatening course 
and which case will not. To date, no enough data exists 
regarding the presence of general predictors for vision-
threatening disease.  
 
Abstract 
Cataract Extraction on One Seeing Eye in Patient with 
Behcet’s Disease  
Nurul Fitri Shabrina, Dicky Hermawan, Randi 
Montana 
Introduction : Behcet’s Disease is autoimmune relapsing 
systemic vasculitis of unknown that can cause uveitis and 
affect the anterior and posterior segment of the eye. 
Cataract is the most common complication of anterior 
segment caused by recurrent uveitis. This case was to 
report the outcomes and complications of cataract surgery 
in patients with Behçet's disease. Case report: A of 35 
years old man complained progressive visual loss since 6 
months before admission with VA 1 meter finger 
counting and NLP.  There was history of recurrent 
redness on both eyes accompanied by blurred vision and 
pain, oral aphtosis, and genital aphtosis since three years 
before admission but didn’t seek help because of low 
access to healthcare in his previous home. From anterior 
segment examination there was posterior synechia, cloudy 
lens, pupil secclusion, rubeosis iridis, flare and cell 
suggesting chronic uveitis. There was elevated IOP of 
43.4 mmHg on left eye. Retinal vasculitis was found on 
posterior segment examination.     Result: After 
combination of methylprednisolone and azathioprine for 
one  year, there were improvement of quieter condition on 
both eyes and decreased left eye IOP of 37.2 mmHg. Lens 
extraction with iris retractor was done after three months 
of no inflammatory response. Despite uneventfull surgery 
and combination of immunosupresive medication, the 
visual acuity are not much improved and there was optic 
atrophy from the complication of chronic Behcet’s 
disease. Conclusion: In patient with chronic Behcet’s 
disease, ocular involvement can affect both anterior and 
posterior segments with poor visual outcome regarding its 
complication 
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